Mylan Scores IPR Victory, Paving The Way For Follow-On Lantus

 
• By Jessica Merrill

US Patent and Trademark Office invalidated two patents covering Sanofi's Lantus vial, clearing the way for Mylan to launch a follow-on product after FDA approval.

insulin word on checkered paper sheet- vector illustration - Vector

More from Biosimilars

More from Biosimilars & Generics